Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

About this trial

Evaluate the protein expression of lactate dehydrogenase enzyme (LDHA) and MCT-1/-4 transporters, involved in lactate synthesis and transport, in prostate carcinoma tissues from severely overweight/obese (BMI \> 27.5) and non-severely overweight/normoweight (BMI \< 27.5) patients affected by prostate carcinoma.

ii. Characterize the immune infiltrate in the prostate carcinoma of the aforementioned patients.

iii. Assess the association between intra-tumoral lactate accumulation (using LDHA and MCT-4 protein expression levels as readouts) and alterations in the tumor immune microenvironment and/or deregulation of relevant oncogenic pathways.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

affected by prostate cancer

Disqualifiers

None

Trial population

patients affected bt prostate cancer both obese or not obese

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • observational study

    Other intervention

    observational study

Treatment groups

25 Participants
are divided into 2 treatment groups
Group A: obese individuals [Body Mass Index (BMI) > 30 affected by prostate cancer1 intervention
Group B: normal-weight individuals [18 < BMI < 25] affected by prostate cancer0 interventions

Trial outcomes

Primary outcomes

1

Assess the protein expression of LDHA enzyme and MCT-1/-4 transporters in prostate carcinoma

Time frame
4 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.